DUOJIA SHEN: Open Payments
NPI 1598174575 · AVON, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,114 in 172 payments from 15 companies in 2025. Trend: 2023 $3,401 · 2024 $3,313 · 2025 $4,114
Food & beverage: $4,014Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 37 | $751 |
| Amgen Inc. | 28 | $710 |
| UCB, Inc. | 17 | $458 |
| E.R. Squibb & Sons, L.L.C. | 10 | $316 |
| Novartis Pharmaceuticals Corporation | 14 | $288 |
| AstraZeneca Pharmaceuticals LP | 13 | $270 |
| GlaxoSmithKline, LLC. | 11 | $267 |
| PFIZER INC. | 11 | $213 |
| Actelion Pharmaceuticals US, Inc. | 5 | $205 |
| Janssen Biotech, Inc. | 8 | $175 |
Products named: Bimzelx, RINVOQ, SKYRIZI, COSENTYX, KRYSTEXXA, SAPHNELO, TAVNEOS, BENLYSTA.
Industry payments across CT — which companies pay providers there.
